Dual-Labelled Nanoparticles Inform on the Stability of Fluorescent Labels In Vivo

Author:

Roussel Sabrina1ORCID,Grenier Philippe1ORCID,Chénard Valérie1,Bertrand Nicolas1ORCID

Affiliation:

1. Faculty of Pharmacy, CHU de Quebec Research Center, Université Laval, 2705 Laurier Blvd, Québec, QC G1V 4G2, Canada

Abstract

Fluorescent labelling is commonly used to monitor the biodistribution of nanomedicines. However, meaningful interpretation of the results requires that the fluorescent label remains attached to the nanomedicine. In this work, we explore the stability of three fluorophores (BODIPY650, Cyanine 5 and AZ647) attached to polymeric hydrophobic biodegradable anchors. Using dual-labelled poly(ethylene glycol)-b-poly(lactic acid) (PEG-PLA) nanoparticles that are both radioactive and fluorescent, we investigated how the properties of the fluorophores impact the stability of the labelling in vitro and in vivo. Results suggest that the more hydrophilic dye (AZ647) is released faster from nanoparticles, and that this instability results in misinterpretation of in vivo data. While hydrophobic dyes are likely more suitable to track nanoparticles in biological environments, quenching of the fluorescence inside the nanoparticles can also introduce artefacts. Altogether, this work raises awareness about the importance of stable labelling methods when investigating the biological fate of nanomedicines.

Funder

Natural Sciences and Engineering Research Council of Canada

Faculty of Pharmacy of Université Laval

Canadian Funds for Innovation

Fonds de Recherche du Québec—Santé

Fondation du CHU de Quebec-Desjardins

Fonds d’Enseignement et de Recherche

CHU de Québec Research Center

Fondation du CHU de Québec

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference49 articles.

1. Nanopharmaceuticals and nanomedicines currently on the market: Challenges and opportunities;Farjadian;Nanomedicine,2019

2. One-Step Assembly of a Biomimetic Biopolymer Coating for Particle Surface Engineering;Liu;Adv. Mater.,2018

3. Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo;Ashton;Sci. Transl. Med.,2016

4. U.S Departement of Health and Human Services (2022). Drug Products, Including Biological Products, that Contain Nanomaterials; Guidance for Industry Center for Durg Evaluation and Research (CDER).

5. In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles;Kumar;ACS Nano,2010

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3